Lupin, Yoshindo Form JV To Produce Lupin Biosimilars For Japan
This article was originally published in PharmAsia News
Executive Summary
Lupin and Yoshindo have joined in creating a joint venture, YL Biologics to take biosimilar drugs through clinical trials and to marketing approval in Japan.